Validating the Shortened Quality of Life in Childhood Epilepsy Questionnaire (QOLCE-55) in a Sample of Children with Drug-resistant Epilepsy
Affiliations
Objective: The aim of this study was to validate the newly developed shortened Quality of Life in Childhood Epilepsy Questionnaire (QOLCE-55) in a sample of children with drug-resistant epilepsy.
Methods: Data came from 136 children enrolled in the Impact of Pediatric Epilepsy Surgery on Health-Related Quality of Life Study (PEPSQOL), a multicenter prospective cohort study. Confirmatory factor analysis was used to assess the higher-order factor structure of the QOLCE-55. Convergent and divergent validity was assessed by correlating subscales of the KIDSCREEN-27 with the QOLCE-55. Measurement equivalence of the QOLCE-55 was evaluated using multiple-group confirmatory factor analysis of children with drug-resistant epilepsy from PEPSQOL versus children with new-onset epilepsy from HERQULES (Health-Related Quality of Life in Children with Epilepsy Study).
Results: The higher-order factor structure of the QOLCE-55 demonstrated adequate fit: Comparative Fit Index (CFI) = 0.948; Tucker-Lewis Index (TLI) = 0.946; Root Mean Square of Approximation (RMSEA) = 0.060 (90% confidence interval [CI] 0.054-0.065); Weighted Root Mean Square Residuals (WRMR) = 1.247. Higher-order factor loadings were strong, ranging from λ = 0.74 to 0.81. Internal consistency reliability was excellent (α = 0.97, subscales α > 0.82). QOLCE-55 subscales demonstrated moderate to strong correlations with similar subscales of the KIDSCREEN-27 (ρ = 0.43-0.75) and weak to moderate correlations with dissimilar subscales (ρ = 0.25-0.42). The QOLCE-55 demonstrated partial measurement equivalence at the level of strict invariance - χ (2,823) = 3,727.9, CFI = 0.961, TLI = 0.962, RMSEA = 0.049 (0.044, 0.053), WRMR = 1.834.
Significance: The findings provide support for the factor structure of the QOLCE-55 and contribute to its robust psychometric profile as a reliable and valid measure. Researchers and health practitioners should consider the QOLCE-55 as a viable option for reducing respondent burden when assessing health-related quality of life in children with epilepsy.
Impact of Vitamin D and IL-1β on Quality of Life in Pediatric Drug-Resistant Epilepsy.
Saing J, Sari D, Supriatmo , Fitri A, Pratama M J Multidiscip Healthc. 2024; 17:5571-5581.
PMID: 39619161 PMC: 11606344. DOI: 10.2147/JMDH.S493116.
Leda M, Puka K, Bax K, Gagnier J, Tassiopoulos K, Speechley K Epilepsia. 2024; 65(12):3536-3544.
PMID: 39382454 PMC: 11647425. DOI: 10.1111/epi.18140.
Alfonso D, Ailion A, Semaan N, Davalbhakta E, Bearden D Epilepsy Behav Rep. 2024; 27:100700.
PMID: 39184195 PMC: 11342123. DOI: 10.1016/j.ebr.2024.100700.
Quality of Life of Developmentally Normal Children With Epilepsy and Their Siblings.
Navik A, Aggarwal A, Singh A, Malhotra R Cureus. 2023; 15(8):e44067.
PMID: 37753007 PMC: 10518430. DOI: 10.7759/cureus.44067.
Marghalani Y, Aljabri A, Kaneetah A, Alzahrani S, Hmoud M, Attar A Cureus. 2023; 15(7):e42417.
PMID: 37637584 PMC: 10449233. DOI: 10.7759/cureus.42417.